Digestive and nutritional management in patients with cystic fibrosis;Prise en charge digestive et nutritionnelle

Archives de Pediatrie

Volumn 8, Issue SUPPL. 5, 2001, Pages

  Munck, A ^a   Navarro, J ^a   Debray, D ^b   Turck, D ^c  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b BICÊTRE HOSPITAL   (France)

^c LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

KREON; PANCREAS EXTRACT; PANCRELIPASE; URSODEOXYCHOLIC ACID;

CYSTIC FIBROSIS; DIAGNOSTIC APPROACH ROUTE; DISEASE ASSOCIATION; GASTROESOPHAGEAL REFLUX; HUMAN; INTESTINE OBSTRUCTION; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PANCREAS EXOCRINE INSUFFICIENCY; REVIEW; SYMPTOMATOLOGY;

EID: 0035682572     PISSN: 0929693X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (52)

1. New insights on gastroesophageal reflux in cystic fibrosis by longitudinal follow up
2. Gastrointestinal pH, motility, transit and permeability in cystic fibrosis
3. Fréquence du reflux gastro-oeæsophagien chez le nourrisson et le jeune enfant atteint de mucoviscidose
4. Mechanisms of gastroesophageal reflux in cystic fibrosis
5. Esophageal pH monitoring data during chest physiotherapy
6. Gastroesophageal reflux and esophagitis in cystic fibrosis
7. 51Cr-EDTA and orocaecal transit time in cystic fibrosis
8. Cisapride in cystic fibrosis
9. Constipation and meconium ileus equivalent in patients with cystic fibrosis
10. Lavage treatment of distal intestinal obstruction syndrome in children with cystic fibrosis
11. The spectrum of appendiceal disease in cystic fibrosis
12. A right lower quadrant mass in cystic fibrosis: A diagnostic challenge
13. Ultrasonography detects appendicular mucocele in cystic fibrosis patients suffering recurrent abdominal pain
14. Appendicitis in cystic fibrosis
15. Treatment and prognosis of rectal prolapse in cystic fibrosis
16. Crohn's disease and cystic fibrosis
17. Mucoviscidose
18. Cystic fibrosis: Nutritional consequences and management
19. Exploration de la sécrétion pancréatique exocrine
20. Gastrointestinal and pancreatic disease in cystic fibrosis
21. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis
22. Strictures of ascending colon in cystic fibrosis and high-strength pancreatic enzymes
23. Fibrosing colonopathy in cystic fibrosis: Results of a case-control study
24. Use of pancreatic enzyme supplements for patients with cystic fibrosis in the context of fibrosing colonopathy
25. Fibrosing colonopathy associated with pancreatic enzymes
26. Effect of taurine supplementation on fat and energy absorption in cystic fibrosis
27. Placebo-controlled trial of misoprostol in cystic fibrosis
28. Improvement of fecal fat excretion after addition of omeprazole to pancrease in cystic fibrosis is related to residual exocrine function of the pancreas
29. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children
30. Liver cirrhosis in cystic fibrosis: Therapeutic implications and long term follow-up
31. Liver involvement in cystic fibrosis
32. Outcome of cystic fibrosis-associated liver cirrhosis: Management of portal hypertension
33. Natural history of liver disease in cystic fibrosis
34. Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosis
35. Neonatal cholestasis as the presenting feature in cystic fibrosis
36. Ursodeoxycholic acid for liver disease associated with cystic fibrosis: A double blind multicenter trial
37. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease
38. Decompression of portal hypertension in a child with cystic fibrosis after transjugular intrahepatic portosystemic shunt placement
39. Cystic fibrosis and portal hypertension: Interest of partial splenectomy
40. Liver transplantation for hepatic cirrhosis in cystic fibrosis
41. Combined lung and liver transplantation in patients with cystic fibrosis: A 4 1/2-year experience
42. A comparison of survival, growth and pulmonary function in patients with cystic fibrosis in Boston and Toronto
43. The relation between genotype and phenotype in cystic fibrosis analysis of the most common mutation ((F508)
44. Energy expenditure and genotype of children with cystic fibrosis
45. Nutritional assessment and management in cystic fibrosis: A consensus report
46. The assessment of nutritional status in children
47. New norms of upper limb fat and muscle areas for assessment of nutritional status
48. Mesure de l'élastase 1 fécale par immunoréactivité: Une nouvelle approche indirecte de la fonction pancréatique
49. Prise en charge nutritionnelle dans la mucoviscidose
50. Energy balance and nutritional support in cystic fibrosis
51. Nutritional management of cystic fibrosis
52. Improvement of nutritional status and lung function after long term nocturnal gastrostomy feedings in cystic fibrosis